Skip to content

Evaluation of effects of test food intake on liver function and ALT in healthy volunteers

Effects of food intake on liver function and ALT - Effects on liver function and ALT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000041566
Enrollment
60
Registered
2020-08-26
Start date
2020-08-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer

Interventions

Take control food for 12 weeks Take test food once a day for 12 weeks Take test food twice a day for 12 weeks Take test food 4 times a day for 12 weeks

Sponsors

Shinanozaka Clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Person who are registered in Shinanokai clinical trial volunteer association 2)Healthy persons aged 45 to under 75 3)Person with serum ALT of 31 to 50 IU/L at observation period 1 and observation period 2 (before ingestion) 4)Person who can obtain written consent from the person

Exclusion criteria

Exclusion criteria: 1)Person who continue to take prescription drugs 2)Person who are on diet or exercise therapy 3)Pregnant women, lactating women and person who have or are willing to become pregnant 4)Person who are unable to comply with the intake management of test foods 5)Person who are allergic to the test food 6)Person who have participated in other clinical trials within the past 3 months 7)Person who have taken Misatol or commercial plum extract within the past 3 months 8)Person who regularly take functional foods related to liver function improvement 9)Others, a person who is judged unfit by the physician in charge of this study

Design outcomes

Primary

MeasureTime frame
Measured ALT value and ALT change amount

Secondary

MeasureTime frame
1)Measured AST value 2)Measured GGT value 3)Measured type4collagen7s value 4)Measured Ferritin value 5)Liver disease scoring

Countries

Japan

Contacts

Public ContactMikio Sasaki

Shinanozaka Clinic Clinical Trial Department

m-sasaki@shinanokai.com0353663006

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026